Literature DB >> 16043148

The use of pimonidazole to characterise hypoxia in the internal environment of an in vivo tissue engineering chamber.

S O P Hofer1, G M Mitchell, A J Penington, W A Morrison, R RomeoMeeuw, E Keramidaris, J Palmer, K R Knight.   

Abstract

UNLABELLED: The distribution of hypoxic cells in an in vivo tissue engineering chamber was investigated up to 28 days post-implantation.
METHODS: Arteriovenous loops were constructed and placed into bi-valved polycarbonate chambers containing 2 x 10(6) rat fibroblasts in basement membrane gel (BM gel). Chambers were inserted subcutaneously in the groin of male rats and harvested at 3 (n = 6), 7 (n = 6), 14 (n = 4) or 28 (n = 4) days. Ninety minutes before harvest, pimonidazole (60 mg/kg) was injected intraperitoneally. Chamber tissue was removed, immersion fixed, paraffin embedded, sectioned and stained immunohistochemically using hypoxyprobe-1 Mab that detects reduced pimonidazole adducts forming in cells, where pO2 < 10 mmHg.
RESULTS: At 3 days a fibrin clot/BM gel framework filled the chamber. Seeded fibroblasts had largely died. The majority of 3 day chambers did not demonstrate tissue growth from the AV loop nor was pimonidazole binding present in these chambers. In one chamber in which tissue growth had occurred strong pimonidazole binding was evident within the new tissue. In four out of six 7 day chambers a broader proliferative zone existed extending up to 0.4 mm (approximately) from the AV loop endothelium which demonstrated intense pimonidazole binding. The two remaining 7 day chambers displayed even greater tissue growth (leading edge > 0.7 mm from the AV loop endothelium), but very weak or no pimonidazole binding. At 14 and 28 days the fibrin/BM gel matrix was replaced by mature vascularised connective tissue that did not bind pimonidazole.
CONCLUSION: Employing a tissue engineering chamber, new tissue growth extending up to 0.4 mm from the AV loop endothelium (chambers < or = 7 days) demonstrated intense pimonidazole binding and, therefore, hypoxia. Tissue growth greater than 0.5 mm from the AV loop endothelium (7-28 days chambers) did not exhibit pimonidazole binding due to a significant increase in the number of new blood vessels and was, therefore, adequately oxygenated.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16043148     DOI: 10.1016/j.bjps.2005.04.033

Source DB:  PubMed          Journal:  Br J Plast Surg        ISSN: 0007-1226


  11 in total

1.  [De-novo generation of vascularized tissue using different configurations of vascular pedicles in perforated and closed chambers].

Authors:  Jürgen H Dolderer; Andreas Kehrer; Stefan M Schiller; Ulrich H Schröder; Konrad Kohler; Hans-Eberhard Schaller; Dorothea Siegel-Axel
Journal:  Wien Med Wochenschr       Date:  2010-03

2.  BMP9 regulates endoglin-dependent chemokine responses in endothelial cells.

Authors:  Kira Young; Barbara Conley; Diana Romero; Eric Tweedie; Christine O'Neill; Ilka Pinz; Louise Brogan; Volkhard Lindner; Lucy Liaw; Calvin P H Vary
Journal:  Blood       Date:  2012-09-26       Impact factor: 22.113

3.  Phosphorylation of cAMP response element binding protein (CREB) as a marker of hypoxia in pituitary adenoma.

Authors:  Daijiro Morimoto; Daizo Yoshida; Masahiro Noha; Masanori Suzuki; R Yoshiyuki Osamura; Akira Teramoto
Journal:  J Neurooncol       Date:  2006-04-06       Impact factor: 4.130

4.  TNF, acting through inducibly expressed TNFR2, drives activation and cell cycle entry of c-Kit+ cardiac stem cells in ischemic heart disease.

Authors:  Rafia S Al-Lamki; Wanhua Lu; Jun Wang; Jun Yang; Timothy J Sargeant; Richard Wells; Chenqu Suo; Penny Wright; Martin Goddard; Qunhua Huang; Amir H Lebastchi; George Tellides; Yingqun Huang; Wang Min; Jordan S Pober; John R Bradley
Journal:  Stem Cells       Date:  2013-09       Impact factor: 6.277

5.  Trauma-hemorrhage and hypoxia differentially influence kupffer cell phagocytic capacity: role of hypoxia-inducible-factor-1alpha and phosphoinositide 3-kinase/Akt activation.

Authors:  Chi-Hsun Hsieh; Eike A Nickel; Jun-Te Hsu; Martin G Schwacha; Kirby I Bland; Irshad H Chaudry
Journal:  Ann Surg       Date:  2009-12       Impact factor: 12.969

6.  Neovascularization in an arterio-venous loop-containing tissue engineering chamber: role of NADPH oxidase.

Authors:  F Jiang; G Zhang; I Hashimoto; B S Kumar; S Bortolotto; W A Morrison; G J Dusting
Journal:  J Cell Mol Med       Date:  2008-10       Impact factor: 5.310

7.  Flow increase is decisive to initiate angiogenesis in veins exposed to altered hemodynamics.

Authors:  Volker J Schmidt; Johannes G Hilgert; Jennifer M Covi; Nico Leibig; Johanna O Wietbrock; Andreas Arkudas; Elias Polykandriotis; Cor de Wit; Raymund E Horch; Ulrich Kneser
Journal:  PLoS One       Date:  2015-01-30       Impact factor: 3.240

8.  Hypoxia inducible factor 1α in vascular smooth muscle cells promotes angiotensin II-induced vascular remodeling via activation of CCL7-mediated macrophage recruitment.

Authors:  Dan Qi; Ming Wei; Shiyu Jiao; Yanting Song; Xia Wang; Guomin Xie; Joseph Taranto; Ye Liu; Yan Duan; Baoqi Yu; Huihua Li; Yatrik M Shah; Qingbo Xu; Jie Du; Frank J Gonzalez; Aijuan Qu
Journal:  Cell Death Dis       Date:  2019-07-18       Impact factor: 8.469

9.  Angiogenesis and tissue formation driven by an arteriovenous loop in the mouse.

Authors:  Richard Wong; Roberto Donno; Christopher Y Leon-Valdivieso; Urmas Roostalu; Brian Derby; Nicola Tirelli; Jason K Wong
Journal:  Sci Rep       Date:  2019-07-19       Impact factor: 4.379

10.  Neutrophil depletion enhanced the Clostridium novyi-NT therapy in mouse and rabbit tumor models.

Authors:  Verena Staedtke; Tyler Gray-Bethke; Guanshu Liu; Eleni Liapi; Gregory J Riggins; Ren-Yuan Bai
Journal:  Neurooncol Adv       Date:  2021-12-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.